GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury

Supplemental Digital Content is available in the text. Rationale: Pyroptosis is a morphologically and mechanistically distinct form of cell death and is characterized by GSDMD (gasdermin D) or GSDME (gasdermin E)-mediated necrosis with excessive inflammatory factor release. Cardiomyocyte necrosis and inflammation play key roles in the pathophysiology of myocardial ischemia/reperfusion (I/R) injury. However, whether cardiomyocytes undergo pyroptosis and the underlying mechanism in myocardial I/R injury remain unclear. Objective: We aimed to investigate the role of pyroptosis in myocardial I/R injury. Methods and Results: In vivo and in vitro experiments were used to investigate pyroptosis of cardiomyocyte and the associated mechanisms during I/R injury. Wild-type, Myh6-Cre, and cardiomyocyte-specific GSDMD-deficient male mice were subjected to I/R. Human peripheral blood samples were collected from patients with acute ST-segment–elevation myocardial infarction or control patients at 0, 1, and 24 hours after percutaneous coronary intervention in our department. The serum levels of GSDMD were measured by ELISA. Hypoxia/reoxygenation induced cardiomyocyte pyroptosis and the release of mature IL (interleukin)-18 but not IL-1β, which mechanistically resulted from GSDMD cleavage by caspase-11 in cardiomyocytes. Furthermore, GSDMD gene deletion blocked hypoxia/reoxygenation-induced cardiomyocyte pyroptosis and IL-18 release. GSDMD and its pyroptosis-inducing N-terminal fragment were upregulated in myocardial tissues after I/R injury. Immunofluorescence analysis showed that GSDMD was mainly localized in cardiomyocytes. GSDMD deficiency in cardiomyocytes significantly reduced the I/R-induced myocardial infarct size. Moreover, increased GSDMD serum levels were detected in patients exhibiting I/R injury 1 hour after percutaneous coronary intervention for ST-segment–elevation myocardial infarction. Conclusions: Our results show that GSDMD-mediated cardiomyocyte pyroptosis is a key event during myocardial I/R injury and that the caspase-11/GSDMD pathway may be essential to this process. Additionally, GSDMD inhibition significantly reduces cardiomyocyte pyroptosis and I/R-induced myocardial injury. Graphic Abstract: A graphic abstract is available for this article.

[1]  Shuchen Zhang,et al.  Ferroptosis as a novel therapeutic target for cardiovascular disease , 2021, Theranostics.

[2]  G. Heusch.  Myocardial ischaemia–reperfusion injury and cardioprotection in perspective , 2020, Nature Reviews Cardiology.

[3]  L. Galluzzi,et al.  Oncogene-induced senescence and tumour control in complex biological systems , 2018, Cell Death & Differentiation.

[4]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[5]  E. Dueber,et al.  Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions. , 2017, Trends in immunology.

[6]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[7]  Dacheng Wang,et al.  Erratum: Pore-forming activity and structural autoinhibition of the gasdermin family , 2016, Nature.

[8]  R. Foo,et al.  A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. , 2016, Circulation research.

[9]  C. Bryant,et al.  The killer protein Gasdermin D , 2016, Cell Death and Differentiation.

[10]  V. Hornung,et al.  Pore formation by GSDMD is the effector mechanism of pyroptosis , 2016, The EMBO journal.

[11]  H. Stahlberg,et al.  GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death , 2016, The EMBO journal.

[12]  J. Lieberman,et al.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.

[13]  V. Dixit,et al.  GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes , 2016, Proceedings of the National Academy of Sciences.

[14]  J. Mayerle,et al.  Necrosis, Apoptosis, Necroptosis, Pyroptosis: It Matters How Acinar Cells Die During Pancreatitis , 2016, Cellular and molecular gastroenterology and hepatology.

[15]  J. Abe,et al.  Pyroptosis as a Regulated Form of Necrosis: PI+/Annexin V-/High Caspase 1/Low Caspase 9 Activity in Cells = Pyroptosis? , 2016, Circulation research.

[16]  L. Galluzzi,et al.  Regulated cell death and adaptive stress responses , 2016, Cellular and Molecular Life Sciences.

[17]  L. Galluzzi,et al.  Caspases Connect Cell-Death Signaling to Organismal Homeostasis. , 2016, Immunity.

[18]  C. Vrints,et al.  Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarction , 2016, European heart journal. Acute cardiovascular care.

[19]  Chuan-Qi Zhong,et al.  Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion , 2015, Cell Research.

[20]  Si Ming Man,et al.  Gasdermin D: the long-awaited executioner of pyroptosis , 2015, Cell Research.

[21]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[22]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[23]  P. Libby,et al.  Targeting Interleukin-1&bgr; Reduces Leukocyte Production After Acute Myocardial Infarction , 2015, Circulation.

[24]  E. Miao,et al.  Pyroptotic cell death defends against intracellular pathogens , 2015, Immunological reviews.

[25]  F. Van de Werf,et al.  Evolving therapies for myocardial ischemia/reperfusion injury. , 2015, Journal of the American College of Cardiology.

[26]  C. Patterson,et al.  Depletion of PHD3 Protects Heart from Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis , 2015, Journal of molecular and cellular cardiology.

[27]  P. Ostadal,et al.  Sex‐based differences in cardiac ischaemic injury and protection: therapeutic implications , 2014, British journal of pharmacology.

[28]  Harlan M Krumholz,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[29]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[30]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[31]  Lawrence Buja,et al.  Oncosis: an important non-apoptotic mode of cell death. , 2012, Experimental and molecular pathology.

[32]  Douglas Losordo,et al.  CXC-Chemokine Receptor 4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia/Reperfusion Injury via Endothelial Nitric Oxide Synthase–Dependent Mechanism , 2012, Circulation.

[33]  T. Noda,et al.  Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury , 2011, Circulation.

[34]  J. Gorman,et al.  Sex-related resistance to myocardial ischemia-reperfusion injury is associated with high constitutive ARC expression. , 2010, American journal of physiology. Heart and circulatory physiology.

[35]  R. Kitsis,et al.  Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.

[36]  Xiaodong Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[37]  N. Frangogiannis,et al.  The role of IL-1 in the pathogenesis of heart disease , 2009, Archivum Immunologiae et Therapiae Experimentalis.

[38]  F. Mach,et al.  The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury , 2009, Thrombosis and Haemostasis.

[39]  A. J. Valente,et al.  Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury* , 2009, Journal of Biological Chemistry.

[40]  B. Cookson,et al.  Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.

[41]  P. Armstrong,et al.  ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial , 2008, Circulation.

[42]  C. Gabay,et al.  IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.

[43]  Meijing Wang,et al.  INTERLEUKIN 18 IN THE HEART , 2007, Shock.

[44]  E. Murphy,et al.  Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. , 2007, Cardiovascular research.

[45]  C. Sasakawa,et al.  Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected Macrophages , 2007, PLoS pathogens.

[46]  L. Hillis,et al.  Myocardial infarction and the open-artery hypothesis. , 2006, The New England journal of medicine.

[47]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[48]  Zhi-Qing Zhao.  Oxidative stress-elicited myocardial apoptosis during reperfusion. , 2004, Current opinion in pharmacology.

[49]  I. McInnes,et al.  Interleukin‐18 , 2003, Journal of leukocyte biology.

[50]  G. Fantuzzi,et al.  Overview of interleukin‐18: more than an interferon‐γ inducing factor , 1998, Journal of leukocyte biology.

[51]  M. Ovize,et al.  A fresh look at reperfusion injury. , 1998, Cardiovascular research.

[52]  S. Tanuma,et al.  Inhibitors of poly(ADP‐ribose) polymerase suppress nuclear fragmentation and apoptotic‐body formation during apoptosis in HL‐60 cells , 1997, FEBS letters.

[53]  M. Entman,et al.  Myocardial ischemia and reperfusion: a murine model. , 1995, The American journal of physiology.

[54]  A. Wyllie.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[55]  L. Becker.  Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.